Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-023126
Filing Date
2026-05-14
Accepted
2026-05-14 16:31:37
Documents
49
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 717978
2 EX-31.1 ex31-1.htm EX-31.1 15917
3 EX-31.2 ex31-2.htm EX-31.2 16164
4 EX-32.1 ex32-1.htm EX-32.1 8287
  Complete submission text file 0001493152-26-023126.txt   4553343

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20260331.xsd EX-101.SCH 34921
6 XBRL CALCULATION FILE brtx-20260331_cal.xml EX-101.CAL 39977
7 XBRL DEFINITION FILE brtx-20260331_def.xml EX-101.DEF 170569
8 XBRL LABEL FILE brtx-20260331_lab.xml EX-101.LAB 304960
9 XBRL PRESENTATION FILE brtx-20260331_pre.xml EX-101.PRE 244306
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 634732
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 26979627
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)